Skip to Main Content

A unit of Fresenius Kabi, a major supplier of infused and intravenously administered drugs, has agreed to plead guilty to hiding and destroying records before a 2013 plant inspection by the Food and Drug Administration, and will also pay $50 million in fines and forfeiture.

At issue is a plant operated in West Bengal, India, by Fresenius Kabi Oncology, which makes active pharmaceutical ingredients for various cancer medicines distributed in the U.S. According to the U.S. Department of Justice, plant managers directed employees to remove computers and documents, and delete other records that indicated proper manufacturing procedures were not being followed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!